ROSEN, A LEADING AND RANKED FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation
- Written by Newsfile
New York, New York--(Newsfile Corp. - July 28, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) resulting from allegations that Apellis may have issued materially misleading business information to...
